Professor Clare Hoskins
Pure and Applied Chemistry
Personal statement
Professor Clare Hoskins (Chair in Nanomedicine) has been working on cancer nanomedicine for the past 20 years. Her work on nanomedicine applied to cancer medicine has been recognised on a national and international scale. She is highly active within her professional bodies. Professor Hoskins is a Fellow of the RSC. She is an elected Council Member of the RSC Materials Chemistry Council, a committee member (and past Chair) of the RSC Chemical Nanosciences and Nanotechnology Network, she also the Secretary of the UK and Ireland Controlled Release Society. Professor Hoskins has been awarded various prizes (including the Academy of Pharmaceutical Sciences Emerging Researcher award) and medals for her research and leadership. She is currently an Associate Editor of RSC Pharmaceutics and British Journal of Cancer Reports. She leads a vibrant interdisciplinary research group working on the development of a range of multifunctional nanoparticles and their translation into medical therapies both in therapeutics and theranostics. Professor Hoskins has been involved in various different consortium projects or initiatives including EPSRC IRC in Hard-to-Treat Cancer, CRUK funded PaNanoMRI, EU Cost Action Next-MPI and the EPSRC CDT in cyber-physical systems for medicine development and manufacturing.
Prize And Awards
- Strathclyde Medal: Team Award Quilts for Cancer
- Recipient
- 11/10/2022
- Strathclyde Medal: Team Award
- Recipient
- 11/10/2022
- Strathclyde Women in Leadership
- Recipient
- 2021
- North Staffordshire Medical Institute Researcher Award
- Recipient
- 7/11/2019
- Academy of Pharmaceutical Science Emerging Scientist Award
- Recipient
- 23/9/2019
Publications
- Towards electrochemical sensing of gemcitabine release from hybrid nanoparticles in pancreatic cancer cells
- Oluwasanmi Adeolu, Brown Kelly, Hoskins Clare, Dennany Lynn
- Sensors and Diagnostics Vol 4, pp. 966-972 (2025)
- https://doi.org/10.1039/D5SD00110B
- The potential of small extracellular vesicles for pancreatic cancer therapy
- Crow Richard, Kehow Oksana, Hoskins Clare
- RSC Pharmaceutics Vol 2, pp. 1034-1049 (2025)
- https://doi.org/10.1039/D5PM00115C
- Solid lipid nanoparticles in pancreatic cancer treatment
- Dunn Mia, Dymock Lewis, Hoskins Clare
- BJC Reports Vol 3 (2025)
- https://doi.org/10.1038/s44276-025-00130-9
- Nanotechnology and hydrophobic drug solubilisation
- Dymock Lewis, Hoskins Clare
- Fundamentals of Pharmaceutical Nanoscience (2024) (2024)
- https://doi.org/10.1007/978-3-031-59478-6_13
- Multifunctional ionic hydrogel based transdermal delivery of 5-fluorouracil for the breast cancer treatment
- Pansuriya Raviraj, Patel Tapas, Kumar Sugam, Aswal Vinod K, Raje Naina, Hoskins Clare, Kumar Kailasa Suresh, Malek Naved I
- ACS Applied Bio Materials Vol 7, pp. 3110–3123 (2024)
- https://doi.org/10.1021/acsabm.4c00152
- A bio-ionic liquid based self-healable and adhesive ionic hydrogel for the on-demand transdermal delivery of a chemotherapeutic drug
- Pansuriya Raviraj, Doutch James, Parmar Bhagyesh, Kumar Kailasa Suresh, Mahmoudi Najet, Hoskins Clare, Malek Naved I
- Journal of Materials Chemistry B Vol 12, pp. 5479-5495 (2024)
- https://doi.org/10.1039/D4TB00510D
Professional Activities
- Nano-assasins for pancreatic cancer therapy
- Speaker
- 22/2/2022
- The Big Impact of Small for Pancreatic Cancer
- Speaker
- 28/1/2022
- RSC Chemical Nanosciences and Nanotechnology Network Annual Symposium
- Participant
- 2022
- Controlled Release Society , USA
- Participant
- 2022
- Pancreatic Nano-ninjas
- Speaker
- 29/11/2021
- Quilts 4 Cancer: exhibition for participants
- Host
- 15/11/2021
Projects
- TRM curcuminoid analysis of samples
- Hoskins, Clare (Principal Investigator)
- 01-Jan-2025 - 31-Jan-2025
- TRM Analysis
- Hoskins, Clare (Principal Investigator)
- 01-Jan-2024 - 30-Jan-2024
- EPSRC Centre for Doctoral Training in Cyber-physical Systems for Medicine Development and Manufacturing (CEDAR)
- Florence, Alastair (Principal Investigator) Cardona Amengual, Javier (Co-investigator) Hoskins, Clare (Co-investigator) Markl, Daniel (Co-investigator) Perrie, Yvonne (Co-investigator)
- 01-Jan-2024 - 30-Jan-2032
- Caco2 monolayer studies Copy
- Hoskins, Clare (Principal Investigator)
- 01-Jan-2023 - 31-Jan-2023
- NextPharma PhD studentship for Healthcare Nanotechnologies CDT
- Hoskins, Clare (Principal Investigator)
- 01-Jan-2022 - 31-Jan-2026
- Strathclyde CDT: Healthcare Nanotechnologies
- Perrie, Yvonne (Principal Investigator) Rattray, Zahra (Principal Investigator) Hoskins, Clare (Principal Investigator) Faulds, Karen (Principal Investigator) Graham, Duncan (Principal Investigator)
- 01-Jan-2022 - 30-Jan-2025
Contact
Professor
Clare
Hoskins
Pure and Applied Chemistry
Email: clare.hoskins@strath.ac.uk
Tel: 548 2796